The association between AD and oxidative stress is widely investigated as a potential therapeutic target [36,37,38,39,40], and the design of cholinesterase inhibitors with antioxidant properties is considered a promising direction in the development of multifunctional drugs for AD treatment [41,42,43,44,45]. Here, BCHE is linked to Alzheimer disease.